Annual Long Term Debt
$104.49 M
-$2.60 M-2.43%
31 December 2023
Summary:
Apellis Pharmaceuticals annual long term debt is currently $104.49 million, with the most recent change of -$2.60 million (-2.43%) on 31 December 2023. During the last 3 years, it has fallen by -$269.56 million (-72.07%). APLS annual long term debt is now -72.07% below its all-time high of $374.05 million, reached on 31 December 2020.APLS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$463.66 M
-$4.64 M-0.99%
30 September 2024
Summary:
Apellis Pharmaceuticals quarterly long term debt is currently $463.66 million, with the most recent change of -$4.64 million (-0.99%) on 30 September 2024. Over the past year, it has increased by +$359.82 million (+346.52%). APLS quarterly long term debt is now -0.99% below its all-time high of $468.30 million, reached on 30 June 2024.APLS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLS Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.4% | +346.5% |
| 3 y3 years | -72.1% | +123.2% |
| 5 y5 years | +311.7% | +205.3% |
APLS Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.1% | at low | -1.0% | +350.7% |
| 5 y | 5 years | -72.1% | +311.7% | -1.0% | +350.7% |
| alltime | all time | -72.1% | +311.7% | -1.0% | +3784.2% |
Apellis Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $463.66 M(-1.0%) |
| June 2024 | - | $468.30 M(+355.2%) |
| Mar 2024 | - | $102.88 M(-1.5%) |
| Dec 2023 | $104.49 M(-2.4%) | $104.49 M(+0.6%) |
| Sept 2023 | - | $103.84 M(-1.1%) |
| June 2023 | - | $104.95 M(-1.0%) |
| Mar 2023 | - | $106.04 M(-1.0%) |
| Dec 2022 | $107.09 M(-48.0%) | $107.09 M(-0.8%) |
| Sept 2022 | - | $107.95 M(-47.6%) |
| June 2022 | - | $205.99 M(+0.1%) |
| Mar 2022 | - | $205.86 M(-0.1%) |
| Dec 2021 | $206.10 M | $206.10 M(-0.8%) |
| Sept 2021 | - | $207.76 M(-48.8%) |
| June 2021 | - | $405.60 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $406.06 M(+8.6%) |
| Dec 2020 | $374.05 M(+142.2%) | $374.05 M(+1.2%) |
| Sept 2020 | - | $369.44 M(+2.7%) |
| June 2020 | - | $359.58 M(+130.6%) |
| Mar 2020 | - | $155.96 M(+1.0%) |
| Dec 2019 | $154.42 M(+508.5%) | $154.42 M(+1.7%) |
| Sept 2019 | - | $151.87 M(+1172.3%) |
| June 2019 | - | $11.94 M(-2.5%) |
| Mar 2019 | - | $12.24 M(-51.8%) |
| Dec 2018 | $25.38 M(-3.8%) | $25.38 M(-5.7%) |
| Sept 2018 | - | $26.91 M(+0.5%) |
| June 2018 | - | $26.76 M(+0.5%) |
| Mar 2018 | - | $26.62 M(+0.9%) |
| Dec 2017 | $26.39 M | $26.39 M |
FAQ
- What is Apellis Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual long term debt year-on-year change?
- What is Apellis Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly long term debt year-on-year change?
What is Apellis Pharmaceuticals annual long term debt?
The current annual long term debt of APLS is $104.49 M
What is the all time high annual long term debt for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual long term debt is $374.05 M
What is Apellis Pharmaceuticals annual long term debt year-on-year change?
Over the past year, APLS annual long term debt has changed by -$2.60 M (-2.43%)
What is Apellis Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of APLS is $463.66 M
What is the all time high quarterly long term debt for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly long term debt is $468.30 M
What is Apellis Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, APLS quarterly long term debt has changed by +$359.82 M (+346.52%)